Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Co-administered Hookworm Vaccines in Gabonese Children
NCT02839161Phase 1Completed
- Sponsor
- Baylor College of Medicine
- Start
- Jan 2017
- Primary completion
- Dec 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Necator americanus Glutathione-S-Transferase-1 and Na-APR-1 (M74) in hookworm infection (8 arms), sponsored by Baylor College of Medicine. Primary endpoint: Vaccine-Related Adverse Events at Day 380. Started Jan 2017; status: completed.
02
Drugs
Necator americanus Glutathione-S-Transferase-1Na-APR-1 (M74)
03
Conditions
hookworm infection
Beyond the preview
Go deeper on NCT02839161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02839161.